Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model - PubMed (original) (raw)
Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model
Bradley J Turner et al. Neurobiol Dis. 2009 Jun.
Abstract
Mutations in the ubiquitously expressed survival motor neuron 1 (SMN1) and superoxide dismutase 1 (SOD1) genes are selectively lethal to motor neurons in spinal muscular atrophy (SMA) and familial amyotrophic lateral sclerosis (ALS), respectively. Genetic association studies provide compelling evidence that SMN1 and SMN2 genotypes encoding lower SMN protein levels are implicated in sporadic ALS, suggesting that SMN expression is a potential determinant of ALS severity. We therefore sought genetic evidence of SMN involvement in ALS by generating transgenic mutant SOD1 mice on an Smn deficient background. Partial genetic disruption of Smn significantly worsened motor performance and survival in transgenic SOD1(G93A) mice. Furthermore, ALS-linked mutant SOD1 expression severely reduced SMN protein levels, but not transcript, in neuronal culture and mouse models from early presymptomatic disease. SMN protein depletion was linked to the nuclear compartment and a physical interaction between SMN and mutant SOD1 was confirmed in mouse spinal cord. Treatment with the environmental toxin paraquat also depleted SMN protein, implicating oxidative stress in the mechanism underlying SMN deficiency in familial ALS and potentially sporadic disease. In contrast, transgenic SOD1(WT) overexpression in SMA type I mice was incapable of modulating SMN protein levels or disease progression. These data establish that SMN deficiency accelerates phenotypic severity in transgenic familial ALS mice, consistent with an enhancing genetic modifier role. We therefore propose that SMN replacement and upregulation strategies considered for SMA therapy may have protective potential for ALS.
Similar articles
- Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.
Turner BJ, Alfazema N, Sheean RK, Sleigh JN, Davies KE, Horne MK, Talbot K. Turner BJ, et al. Neurobiol Aging. 2014 Apr;35(4):906-15. doi: 10.1016/j.neurobiolaging.2013.09.030. Epub 2013 Oct 24. Neurobiol Aging. 2014. PMID: 24210254 Free PMC article. - Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
Kariya S, Re DB, Jacquier A, Nelson K, Przedborski S, Monani UR. Kariya S, et al. Hum Mol Genet. 2012 Aug 1;21(15):3421-34. doi: 10.1093/hmg/dds174. Epub 2012 May 11. Hum Mol Genet. 2012. PMID: 22581780 Free PMC article. - TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ, Bäumer D, Parkinson NJ, Scaber J, Ansorge O, Talbot K. Turner BJ, et al. BMC Neurosci. 2008 Oct 28;9:104. doi: 10.1186/1471-2202-9-104. BMC Neurosci. 2008. PMID: 18957104 Free PMC article. - Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development.
Bowerman M, Murray LM, Scamps F, Schneider BL, Kothary R, Raoul C. Bowerman M, et al. Eur J Med Genet. 2018 Nov;61(11):685-698. doi: 10.1016/j.ejmg.2017.12.001. Epub 2017 Dec 5. Eur J Med Genet. 2018. PMID: 29313812 Review. - Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Shibata N. Shibata N. Neuropathology. 2001 Mar;21(1):82-92. doi: 10.1046/j.1440-1789.2001.00361.x. Neuropathology. 2001. PMID: 11304046 Review.
Cited by
- An Optimized Comparative Proteomic Approach as a Tool in Neurodegenerative Disease Research.
Kline RA, Lößlein L, Kurian D, Aguilar Martí J, Eaton SL, Court FA, Gillingwater TH, Wishart TM. Kline RA, et al. Cells. 2022 Aug 26;11(17):2653. doi: 10.3390/cells11172653. Cells. 2022. PMID: 36078061 Free PMC article. Review. - Molecular Classification and Interpretation of Amyotrophic Lateral Sclerosis Using Deep Convolution Neural Networks and Shapley Values.
Karim A, Su Z, West PK, Keon M, The Nygc Als Consortium, Shamsani J, Brennan S, Wong T, Milicevic O, Teunisse G, Rad HN, Sattar A. Karim A, et al. Genes (Basel). 2021 Oct 30;12(11):1754. doi: 10.3390/genes12111754. Genes (Basel). 2021. PMID: 34828360 Free PMC article. - SMN complex member Gemin3 self-interacts and has a functional relationship with ALS-linked proteins TDP-43, FUS and Sod1.
Cacciottolo R, Ciantar J, Lanfranco M, Borg RM, Vassallo N, Bordonné R, Cauchi RJ. Cacciottolo R, et al. Sci Rep. 2019 Dec 10;9(1):18666. doi: 10.1038/s41598-019-53508-4. Sci Rep. 2019. PMID: 31822699 Free PMC article. - Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo.
Williamson MG, Finelli MJ, Sleigh JN, Reddington A, Gordon D, Talbot K, Davies KE, Oliver PL. Williamson MG, et al. Hum Mol Genet. 2019 Nov 1;28(21):3584-3599. doi: 10.1093/hmg/ddz190. Hum Mol Genet. 2019. PMID: 31642482 Free PMC article. - Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis.
Tosolini AP, Sleigh JN. Tosolini AP, et al. Front Mol Neurosci. 2017 Dec 7;10:405. doi: 10.3389/fnmol.2017.00405. eCollection 2017. Front Mol Neurosci. 2017. PMID: 29270111 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous